High Quality 99% Tofacitinib Citrate for Hair Growth 540737-29-9
GMP HALAL KOSHER ISO FDA 4 Inquiries
540737-29-9
99%
Foil Bag, Box, Drum
Yes
2022-12-31
Herb Extracts,Cosmetic raw materails,API
-
Product Details
-
Seller Information
-
Inquiry History
-
Description
![]()
Product DescriptionProduct Name
Tofacitinib citrateCAS
540737-29-9MF
C16H20N6O.C6H8O7MW
504.497Appearance
White PowderAssay
99%minSingle impurity
≤0.1%Usage
Treat rheumatoid arthritisDosage
30 nM; intraperitoneal injectio
(1).Tofacitinib citrate is a king of drugs developed by the US pharmaceutical company for treating rheumatoid arthritis, for the treatment of methotrexate inadequate response or intolerance to severe active rheumatoid arthritis (RA) in adult patients. Tofacitinib citrate is approved for the treatment of methotrexate inadequate response or intolerance to severe active rheumatoid joints arthritis (RA) in adult patients.
(2). It can be used as monotherapy or in combination with methotrexate or other non-biological disease-modifying antirheumatic drugs (the DMARD) in combination. This medicine should not be in combination with biological DMARD or strong immunosuppressants (such as cyclosporine and azathioprine) . Tofacitinib citrate is approved by the daily dose of 2 times, each time 5mg. Seven clinical trials evaluated the safety and efficacy of Tofacitinib citrate in moderate to severe active RA in adult patients. In all tests, compared with patients receiving placebo, patients receiving Tofacitinib citrate treatment showed significant improvement in clinical response and physical function.abbreviated as NAD+ and NADH respectively.Function
(1).Tofacitinib citrate is an oral, small molecule drug used to treat adults with moderate-to-severe, active rheumatoid arthritis who have not responded well to being treated with methotrexate. Methotrexate is a disease-modifying antirheumatic drug (DMARD) used to treat rheumatoid arthritis (RA).
(2).Tofacitinib acts to block the body's production of enzymes called Janus kinases (JAKs). JAKs play a role in joint inflammation in RA, which can cause pain, swelling and stiffness. If left untreated, RA inflammation could lead to joint erosions, and organ and tissue damage. It may be used alone or in combination with methotrexate or other DMARDs.
ECHEMI Editorial ReferenceTofacitinib citrate is a JAK1/2/3 inhibitor with IC50s of 1, 20, and 112 nM, respectively.CertificatesBasic Info-
Product Name:
Tofacitinib citrate
Other Name:1-Piperidinepropanenitrile,4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-,(3R,4R)-,2-hydroxy-1,2,3-propanetricarboxylate (1:1);3-Piperidinamine,1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-,(3R,4R)-,2-hydroxy-1,2,3-propanetricarboxylate (1:1);Tasocitinib citrate;CP 690500-10;Tofacitinib citrate;CP 690550-10;Xeljanz;Xeljanz XR
CAS No.:540737-29-9
Molecular Formula:C16H20N6O.C6H8O7
InChIKeys:InChIKey=SYIKUFDOYJFGBQ-YLAFAASESA-N
Molecular Weight:504.497
Exact Mass:504.196869
EC Number:1592732-453-0
HScode:29335990
Categories:
Characteristics-
PSA:
221
XLogP3:0.23418
Appearance:white to beige
Melting Point:201 °C (decomp)
Water Solubility:DMSO: soluble5mg/mL (clear solution; warmed)
Storage Conditions:room temp
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
Reproductive toxicity, Category 1B
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Danger
Hazard statement(s) H302 Harmful if swallowed
H360 May damage fertility or the unborn child
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P203 Obtain, read and follow all safety instructions before use.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
P318 IF exposed or concerned, get medical advice.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Herb Extracts,Cosmetic raw materails,API
-
Location:
1403,Jinye B Block
-
Payment Terms:
TT against copy of documents
-
Average lead Time:
8 days
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
11-50
-
Year of Establishment:
2015
-
-
Inquiry History4 Inquiries
Country Product Purchase Quantity Date Posted
Austria
Tofacitinib citrate
1 G Aug 28, 2026
India
Tofacitinib citrate
10 G Sep 26, 2025
Taiwan, China
Tofacitinib citrate
5 KG Dec 3, 2025
Canada
Tofactinib citrate
10 G Mar 21, 2025 Post an enquiry for this product
- Hot Searches
- tirzepatide research peptide for sale online
- bioglutide peptide for sale
- buying adrenochrome
- sigmoid.volvulus
- hypochlorous acid wholesale supplier
- rubbing alcohol molecular structure
- dayquil ingredients vs nyquil
- chemical compound of acetone
- propanol msds
- acetic acid price
- anhydrous ammonia for sale
- buy adrenochrome
More from this Seller
-
-
-
Factory Supply Pharmaceutical Grade API CAS 129101-54-8 Rivastigmine Tartrate Powder
Pharmaceutical Grade / 99%
-
-
-
-
Formononetin
Pharmaceutical grade / 0.99%
-
-
-
-
Monostearin
Pharmaceutical grade / 0.99%
-
-
-
-
CAS 36791-04-5 99% Purity Ribavirin Powder
Food Grade / 99%
-

